Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N C Fox

Showing results (51-60 of 115) with videos related to

Pageof 12
Sort By:
Lancet (London, England)|July 31, 2001
Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance imagesN C Fox, W R Crum, R I Scahill, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 31, 2010
Familial Alzheimer's disease and inherited prion disease in the UK are poorly ascertainedJ C Stevens, J Beck, A Lukic, et al.
Neurology|August 9, 2006
The effect of APOE genotype on clinical phenotype in Alzheimer diseaseW M van der Flier, S N M Schoonenboom, Y A L Pijnenburg, et al.
Neurocase|August 12, 2005
Can the frontal assessment battery (FAB) differentiate bradykinetic rigid syndromes? Relation of the FAB to formal neuropsychological testingD C Paviour, D Winterburn, S Simmonds, et al.
Neurology|January 24, 2002
Epilepsy presenting as AD: neuroimaging, electroclinical features, and response to treatmentP Høgh, S J Smith, R I Scahill, et al.
Neurology|February 24, 2010
Measuring disease progression in frontotemporal lobar degeneration: a clinical and MRI studyE Gordon, J D Rohrer, L G Kim, et al.
Neurology|November 10, 2004
A presenilin 1 R278I mutation presenting with language impairmentA K Godbolt, J A Beck, J Collinge, et al.
Neurobiology of Aging|August 29, 2006
Automatic calculation of hippocampal atrophy rates using a hippocampal template and the boundary shift integralJ Barnes, R G Boyes, E B Lewis, et al.
Neurology|October 9, 2002
Presenilin-1 mutation (E280G), spastic paraparesis, and cranial MRI white-matter abnormalitiesS O'Riordan, P McMonagle, J C Janssen, et al.
Journal of Neurology|September 26, 2006
Combining short interval MRI in Alzheimer's disease: Implications for therapeutic trialsJ M Schott, C Frost, J L Whitwell, et al.
Pageof 12

Showing results (51-60 of 115) with videos related to

Sort By:
Pageof 12
Lancet (London, England)|July 31, 2001
Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance imagesN C Fox, W R Crum, R I Scahill, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 31, 2010
Familial Alzheimer's disease and inherited prion disease in the UK are poorly ascertainedJ C Stevens, J Beck, A Lukic, et al.
Neurology|August 9, 2006
The effect of APOE genotype on clinical phenotype in Alzheimer diseaseW M van der Flier, S N M Schoonenboom, Y A L Pijnenburg, et al.
Neurocase|August 12, 2005
Can the frontal assessment battery (FAB) differentiate bradykinetic rigid syndromes? Relation of the FAB to formal neuropsychological testingD C Paviour, D Winterburn, S Simmonds, et al.
Neurology|January 24, 2002
Epilepsy presenting as AD: neuroimaging, electroclinical features, and response to treatmentP Høgh, S J Smith, R I Scahill, et al.
Neurology|February 24, 2010
Measuring disease progression in frontotemporal lobar degeneration: a clinical and MRI studyE Gordon, J D Rohrer, L G Kim, et al.
Neurology|November 10, 2004
A presenilin 1 R278I mutation presenting with language impairmentA K Godbolt, J A Beck, J Collinge, et al.
Neurobiology of Aging|August 29, 2006
Automatic calculation of hippocampal atrophy rates using a hippocampal template and the boundary shift integralJ Barnes, R G Boyes, E B Lewis, et al.
Neurology|October 9, 2002
Presenilin-1 mutation (E280G), spastic paraparesis, and cranial MRI white-matter abnormalitiesS O'Riordan, P McMonagle, J C Janssen, et al.
Journal of Neurology|September 26, 2006
Combining short interval MRI in Alzheimer's disease: Implications for therapeutic trialsJ M Schott, C Frost, J L Whitwell, et al.
Pageof 12